Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial to Evaluate the Efficacy of a Neocartilage Implant in the Management of ICRS Grade 3 to 4 Articular Cartilage Lesions of the Knee

NCT01400607 is registered in ClinicalTrials.gov with ISTO Technologies, Inc. as lead sponsor.

NCT NCT01400607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial to Evaluate the Efficacy of a Neocartilage Implant in the Management of ICRS Grade 3 to 4 Articular Cartilage Lesions of the Knee
Lead sponsor
ISTO Technologies, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2011
Completion date
September 30, 2020
Enrollment
14 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute cartilage injury, articular cartilage disorder, chronic cartilage injury, defect of articular cartilage, degeneration; articular cartilage